MGRO.V - MustGrow Biologics Corp.
| Previous Close | 2.1000 |
| Open | 2.1100 |
| Bid | 1.9500 x N/A |
| Ask | 2.0200 x N/A |
| Day's Range | 1.9700 - 2.1100 |
| 52 Week Range | 1.9100 - 3.9500 |
| Volume | |
| Avg. Volume | 14,273 |
| Market Cap | 101.21M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1100 |
| Earnings Date | Nov 29, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NewsfileMustGrow and Janssen PMP, a Division of Janssen Pharmaceutica NV, Extend Exclusive Global Partnership
Exclusive agreement with Janssen PMP, a division of Janssen Pharmaceutica NV, to test MustGrow's mustard-based postharvest food storage preservation technologies for certain applications globally has been extended.Janssen PMP will continue to fund and drive all testing and development work.Saskatoon, Saskatchewan--(Newsfile Corp. - May 23, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow"), and JANSSEN PMP, a division of Janssen Pharmaceutica NV,
NewsfileMustGrow Investor Webcast: Wednesday, April 26th at 4:00pm ET
Saskatoon, Saskatchewan--(Newsfile Corp. - April 24, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), announces that it will be hosting an investor webcast on Wednesday, April 26th at 4:00pm ET. MustGrow's management team will be presenting on recent corporate progress, biological industry developments, and upcoming catalysts. The presentation will be followed by an audience Q&A session. Live Webcast: Wednesday, April 26th at 4:00pm ET / 1:00
NewsfileMustGrow Announces Soil Amendment and Biofertility Programs for Sustainable Agriculture
Plant-based programs to focus on soil and microbiome health, nutrient and water use efficiencies, and plant yields.Products to utilize multiple plant-derived extracts in addition to (and including) the mustard plant to improve beneficial microbial activity and soil health.Soil Amendment and Biofertility are expected to increase MustGrow's target market opportunity in addition to its existing Biocontrol focus.Existing Biocontrol partnerships continue to achieve performance milestones and expand g
- News Direct
MustGrow Biologics sees massive growth in patent portfolio
MustGrow Biologics CEO Corey Giasson joined Steve Darling from Proactive to share news the company has seen its portfolio of patents grow exponentially.
NewsfileMustGrow Reports Growth of Global Patent Portfolio
Mustard-derived intellectual property portfolio has significantly advanced in quantity and scope.Patents have been filed across six continents.Patent portfolio has grown from 23 to 84 in three year period.Saskatoon, Saskatchewan--(Newsfile Corp. - March 8, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to report on the growth of its intellectual property portfolio (the "IP Portfolio") in both quantity and scope, particularly with